Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding

This publication has 14 references indexed in Scilit:

• A Second Generation of Non‐Peptide Cholecystokinin Receptor Antagonists and Their Possible Therapeutic Potential
  Annals of the New York Academy of Sciences, 1994
• Estimation of brain penetration of CCKB receptor antagonists by an ex-vivo binding assay
  Neuropeptides, 1993
• Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area
  Synapse, 1993
• Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity
  European Journal of Pharmacology, 1991
• Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo binding
  European Journal of Pharmacology, 1989
• A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260
  European Journal of Pharmacology, 1989
• Regional distributions of somatostatin and cholecystokinin-like immunoreactivities in rat and bovine brain
  Peptides, 1981
• A specific gastrin receptor site in the rat stomach
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1978
• Immunochemical evidence of cholecystokinin-like peptides in brain
  Nature, 1976
• Cholecystokinin decreases food intake in rats.
  Journal of Comparative and Physiological Psychology, 1973